| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $54.4M | +2.0% |
| Cost of Revenue | $50.1M | +2.2% |
| Gross Profit | $4.3M | -0.9% |
| R&D Expense | $533K | +223.5% |
| SG&A Expense | $11.7M | -40.3% |
| Operating Income | -$15.5M | +28.8% |
| Interest Expense | $1.0M | +16.8% |
| Pre-tax Income | -$16.2M | +12.7% |
| Income Tax | $0 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $21K | +5.3% |
| Accounts Receivable | $13.5M | -31.8% |
| Inventory | $4.4M | -9.1% |
| Current Assets | $25.5M | -30.4% |
| Total Assets | $54.3M | -17.7% |
| Current Liabilities | $25.8M | +5.9% |
| Long-term Debt | $4.1M | -10.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.7M | +50.6% |
| Capital Expenditures | $418K | -68.2% |
| Investing Cash Flow | -$798K | +94.2% |
| Financing Cash Flow | $5.0M | -60.2% |
| Free Cash Flow | -$8.1M | +52.0% |
| — |
| Net Income | -$16.2M | +12.7% |
| EPS (Basic) | -$1.17 | +45.6% |
| EPS (Diluted) | -$1.17 | +45.6% |
| Total Liabilities |
| $29.8M |
| -0.6% |
| Stockholders' Equity | $24.5M | -31.9% |